Patent details

EP2964638 Title: QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR

Basic Information

Publication number:
EP2964638
PCT Application Number:
GB2014050655
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147106207
PCT Publication Number:
WO2014135876
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR
French Title of Invention:
INHIBITEURS QUINAZOLINE DE L'ACTIVATION DES FORMES MUTANTES DU RÉCEPTEUR DE CROISSANCE ÉPIDERMIQUE (EGFR)
German Title of Invention:
CHINAZOLIN-INHIBITOREN ZUR AKTIVIERUNG MUTANTER FORMEN DES EPIDERMALEN WACHSTUMSFAKTOR-REZEPTORS
SPC Number:

Dates

Filing date:
05/03/2014
Grant date:
09/08/2017
EP Publication Date:
13/01/2016
PCT Publication Date:
12/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/08/2017
EP B1 Publication Date:
09/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/08/2017
 
 

Name:
Astrazeneca AB
Address:
Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Agent

Name:
Office FREYLINGER S.A.
From:
23/08/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LI, David, Yunzhi
Address:
China (CN)

2

Name:
WANG, Jiabing
Address:
China (CN)

3

Name:
ZHANG, Xiaolin
Address:
China (CN)

4

Name:
YANG, Zhenfan
Address:
China (CN)

5

Name:
ZENG, Qingbei
Address:
China (CN)

Priority

Priority Number:
PCT/CN2013/072250
Priority Date:
06/03/2013
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
A61K 31/495; A61K 31/505; C07D 403/12;

Publication

European Patent Bulletin

Issue number:
201732
Publication date:
09/08/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2026
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
28/08/2017 Outgoing Correspondence 1
23/08/2017 Power Of Attorney 1